ACHILLES THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7744 USD | -1.20% |
|
-3.20% | -12.89% |
Chart calendar Achilles Therapeutics plc
9f71f04be1a1f96bccc.Es1KOGhxsSDDeQA_t1JGK04TmzAZGpgEo5Ch3RjtIHc.dqg8Tiom6U2QPDgMhiQrXy1D_WZ7TtU32sKYumrbRi95lDx-EgPhZKsNWQ~c2d79d054a7e2efefe5a2b503dc0ffe7
Upcoming events on Achilles Therapeutics plc
Past events on Achilles Therapeutics plc
| 2024-04-22 | Europe ImmunoOncology Summit |
| 2024-04-04 06:45 am | Q4 2023 Earnings Release |
| 2024-02-29 10:30 am | Immuno Oncology 360 Conference |
| 2023-11-13 04:30 pm | Q3 2023 Earnings Release |
| 2023-10-01 | TIL Therapies Summit |
| 2023-09-05 | Advanced Therapies Europe Conference |
| 2023-08-07 04:15 pm | Immuno-Oncology Summit |
| 2023-08-04 07:00 am | Q2 2023 Earnings Release |
| 2023-06-28 12:00 pm | Annual General Meeting |
| 2023-06-21 11:10 am | Immuno-Oncology Europe Summit |
| 2023-06-20 06:00 am | SAE Cell and Gene Therapy Conference |
| 2023-05-10 07:15 am | Q1 2023 Earnings Release |
| 2023-05-02 | LSX World Congress |
| 2023-04-24 11:30 am | Chardan Genetic Medicines and Cell Therapy Manufacturing Summit |
| 2023-03-28 | European Lung Cancer Congress |
| 2023-03-19 | BIO Europe Spring |
| 2023-03-14 08:00 am | Oppenheimer Healthcare Conference |
| 2023-03-09 08:40 am | EQT Life Sciences Bio Capital Europe Conference |
| 2023-03-07 07:05 am | Q4 2022 Earnings Release |
| 2023-01-12 11:15 am | JP Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -60,9 -62,2 2% | -74,7 -72,5 -3.02% | -70,5 -71,7 1.55% | -86,7 |
|
EBIT Million USD | Released Forecast Spread | -33,7 | -64,2 -64,4 0.27% | -78,4 -74,8 -4.79% | -75,3 -76,2 1.22% | -85,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -61,1 -61,0 -0.02% | -71,1 -64,1 -10.78% | -69,2 -72,0 3.99% | -80,0 |
|
Net income Million USD | Released Forecast Spread | -33,2 | -61,1 -61,5 0.6% | -71,2 -64,2 -10.84% | -69,7 -72,0 3.29% | -80,0 |
|
EPS USD | Released Forecast Spread | 0,00 | -2,13 -4,30 50.43% | -1,82 -1,67 -8.82% | -1,74 -1,38 -26.55% | -1,06 |
| Announcement Date | 25/03/21 | 01/03/22 | 07/03/23 | 04/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,5 -18,7 1.23% | -19,0 -20,6 7.82% | -20,5 -21,1 2.62% | -16,0 -22,7 29.25% | -22,8 -19,3 -18.59% | -18,6 -20,4 9.11% | -18,1 -20,7 12.53% | -19,1 -19,9 4.16% | -19,5 -20,4 4.55% | -20,5 | -21,1 | -21,8 | -22,6 | -22,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,2 -18,2 -0.39% | -17,3 -21,1 17.86% | -17,3 -21,1 18.19% | -12,4 -22,5 44.84% | -24,0 -17,1 -40.46% | -17,5 -19,8 11.77% | -16,9 -21,0 19.62% | -16,7 -20,5 18.5% | -18,1 -21,0 13.69% | -20,0 | -20,0 | -20,0 | -20,0 | -22,0 |
|
Net income Million USD | Released Forecast Spread | -18,2 -18,6 2.12% | -17,4 -20,4 14.84% | -17,3 -20,9 17.27% | -12,5 -22,5 44.66% | -24,1 -17,1 -40.7% | -17,5 -19,8 11.55% | -16,8 -21,0 19.78% | -16,7 -20,5 18.62% | -18,6 -21,0 11.29% | -20,0 | -20,0 | -20,0 | -20,0 | -22,0 |
|
EPS USD | Released Forecast Spread | -0,45 -0,76 40.79% | -0,45 -0,51 12.5% | -0,44 -0,57 22.95% | -0,32 -0,65 50.54% | -0,61 -0,22 -174.16% | -0,44 -0,49 9.28% | -0,42 -0,40 -5% | -0,42 -0,40 -5% | -0,46 -0,15 -217.24% | -0,48 | -0,49 | -0,49 | -0,36 | -0,52 |
| Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 07/03/23 | 10/05/23 | 04/08/23 | 13/11/23 | 04/04/24 | - | - | - | - | - |
| Today 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-28 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-28 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 2024-04-28 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-28 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 2024-04-29 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Achilles Therapeutics plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACHL Stock
- Calendar Achilles Therapeutics plc
